Insulin-like growth factor-1 receptor inhibitor, AMG-479, in cetuximab-refractory head and neck squamous cell carcinoma-Reference-Cited by-同舟云学术

Insulin-like growth factor-1 receptor inhibitor, AMG-479, in cetuximab-refractory head and neck squamous cell carcinoma

Published:2010-07-22 Issue:12 Volume:33 Page:1804-1808
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head Neck

Author:

Chung Christine H.,Pohlmann Paula R.,Rothenberg Mace L.,Burkey Brian B.,Parker Joel,Palka Kevin,Aulino Joseph,Puzanov Igor,Murphy Barbara

Publisher

Wiley

Subject

Otorhinolaryngology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hed.21478/fullpdf

Reference19 articles.

1. Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma;Chung;Cancer Res,2006

2. The mechanism of action of methotrexate. II. Augmentation by vincristine of inhibition of deoxyribonucleic aic synthesis by methotrexate in Ehrlich ascites tumor cells;Goldman;Mol Pharmacol,1974

3. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas;Chung;J Clin Oncol,2006

4. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy;Paez;Science,2004

5. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome;Druker;N Engl J Med,2001

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision Medicine Approaches to Overcome Resistance to Therapy in Head and Neck Cancers;Frontiers in Oncology;2021-02-25

2. RTKs in pathobiology of head and neck cancers;Advances in Cancer Research;2020

3. Randomized phase II trial of cixutumumab alone or with cetuximab for refractory recurrent/metastatic head and neck squamous cell carcinoma;Oral Oncology;2018-07

4. BET Inhibition Overcomes Receptor Tyrosine Kinase–Mediated Cetuximab Resistance in HNSCC;Cancer Research;2018-05-23

5. MiR-1275 promotes cell migration, invasion and proliferation in squamous cell carcinoma of head and neck via up-regulating IGF-1R and CCR7;Gene;2018-03